Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NNC6022-0004 SAD and MAD Study in Healthy Adults and Adults With Obesity
NCT07693868Phase 1Recruiting
- Sponsor
- Novo Nordisk
- Start
- Jul 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in obesity comparing NNC6022-0004 with Placebo (2 arms). Primary endpoints: Area under the plasma concentration-time curve from time 0 to last measurable plasma concentration at Day 12, Maximum observed plasma concentration at Day 35 and 1 more. Started Jul 2026; status: recruiting.
02
Drugs
NNC6022-0004
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07693868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07693868.